Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-05

Clinical Trial Update: Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis [Phase 2]

View source ↗

Summary

Update on a Phase 2 clinical trial investigating botulinum toxin injections for treating hyperhidrosis affecting craniofacial, inguinal, palmar, plantar, and tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Carl Swartling | Conditions: Hyperhidrosis | Phase 2 | Status: UNKNOWN